To include your compound in the COVID-19 Resource Center, submit it here.

The mitochondrial peptidase NLN identified as AML target

DISEASE CATEGORY: Cancer

INDICATION: Acute myelogenous leukemia (AML)

Inhibiting the mitochondrial peptidase NLN could treat AML and

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE